Loading...
Loading...
Analysts at Deutsche Bank upgraded Quest Diagnostics
DGX from Hold to Buy.
The price target for Quest Diagnostics has been raised from $64.00 to $75.00.
Quest Diagnostics shares have gained 0.38% over the past 52 weeks, while the S&P 500 index has surged 13.83% in the same period.
Quest Diagnostics' shares fell 0.17% to close at $62.89 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in